πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8563022

Particles for cell targeting

The Board of Regents of the University of Texas System Β· Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8551997

Structural-based inhibitors of the glutathione binding site in aldose reductase, methods o

The Board of Regents of the University of Texas System Β· Granted Tue Oct 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8551526

Preparation of drug particles using evaporation precipitation into aqueous solutions

The Board of Regents of the University of Texas System Β· Granted Tue Oct 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8546371

Nanoparticle formulated glycolipid antigens for immunotherapy

The Board of Regents of the University of Texas System Β· Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8546348

Upregulation of opioid receptors for management

The Board of Regents of the University of Texas System Β· Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8530245

Methods and compositions related to acetylocholine receptor conjugates

The Board of Regents of the University of Texas System Β· Granted Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8530516

Promoting cycling of ApoE4 isoform

The Board of Regents of the University of Texas System Β· Granted Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8529916

High concentration baclofen preparations

The Board of Regents of the University of Texas System Β· Granted Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8529872

Seeds and markers for use in imaging

The Board of Regents of the University of Texas System Β· Granted Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8513209

Micro-RNAS of the MIR-15 family modulate cardiomyocyte survival and cardiac repair

The Board of Regents of the University of Texas System Β· Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8507445

Compositions and methods of use of targeting peptides for diagnosis and therapy of human c

The Board of Regents of the University of Texas System Β· Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8501740

Methods of treatment of opioid tolerance, physical dependence, pain and addiction with inh

The Board of Regents of the University of Texas System Β· Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8501423

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using E

The Board of Regents of the University of Texas System Β· Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8501705

Methods and materials for treating autoimmune and/or complement mediated diseases and cond

The Board of Regents of the University of Texas System Β· Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8486391

Cancer treatment kits using antibodies to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8486423

Thermo-kinetic mixing for pharmaceutical applications

The Board of Regents of the University of Texas System Β· Granted Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8486428

Compositions and methods for making and using acyclic N-halamine-based biocidal polymeric

The Board of Regents of the University of Texas System Β· Granted Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8486410

RLIP76 liposomes for protection against irradiation

The Board of Regents of the University of Texas System Β· Granted Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8481507

Micro-RNAs that control myosin expression and myofiber identity

The Board of Regents of the University of Texas System Β· Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8480637

Nanochanneled device and related methods

The Board of Regents of the University of Texas System Β· Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8470528

Methods and compositions related to adenoassociated virus-phage particles

The Board of Regents of the University of Texas System Β· Granted Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8470976

Methods and compositions for targeting macromolecules into the nucleus

The Board of Regents of the University of Texas System Β· Granted Tue Jun 25 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8466154

Methods and compositions related to wrapping of dehydrons

The Board of Regents of the University of Texas System Β· Granted Tue Jun 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8455621

Influenza A virus vaccines and inhibitors

The Board of Regents of the University of Texas System Β· Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted